This company seems to have been delisted
Reason: Acquired by Amgen
Last recorded trade on: December 8, 2023
Source: https://www.prnewswire.com/news-releases/amgen-completes-acquisition-of-horizon-therapeutics-plc-301949517.html
Reason: Acquired by Amgen
Last recorded trade on: December 8, 2023
Source: https://www.prnewswire.com/news-releases/amgen-completes-acquisition-of-horizon-therapeutics-plc-301949517.html
Horizon Therapeutics
HZNP
$202.94
Share price
0.00%
Change (1 day)
10.92%
Change (1 year)
Categories
Revenue for Horizon Therapeutics (HZNP)
Revenue in 2023 (TTM): NZ$5.97 Billion
According to Horizon Therapeutics
's latest financial reports the company's current revenue (TTM 
) is NZ$6.35 Billion. In 2022 the company made a revenue of NZ$5.71 Billion an increase over the revenue in the year 2021 that were of NZ$4.72 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Horizon Therapeutics from 2009 to 2023
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2023 (TTM) | NZ$5.97 B | 4.62% |
| 2022 | NZ$5.71 B | 21.01% |
| 2021 | NZ$4.72 B | 54.89% |
| 2020 | NZ$3.04 B | 57.99% |
| 2019 | NZ$1.93 B | 7.22% |
| 2018 | NZ$1.80 B | 21.05% |
| 2017 | NZ$1.48 B | 5% |
| 2016 | NZ$1.41 B | 28.05% |
| 2015 | NZ$1.10 B | 191.85% |
| 2014 | NZ$0.37 B | 320.79% |
| 2013 | NZ$90.07 M | 277.42% |
| 2012 | NZ$23.86 M | 168.88% |
| 2011 | NZ$8.87 M | 188.19% |
| 2010 | NZ$3.07 M | |
| 2009 | N/A |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 | NZ$58.32 B | 817.13% | 🇺🇸 USA |
 | NZ$94.35 B | 1,383.73% | 🇬🇧 UK |
 | NZ$111.02 B | 1,645.85% | 🇺🇸 USA |
 | NZ$6.45 B | 1.57% | 🇮🇳 India |
 | NZ$111.97 B | 1,660.73% | 🇺🇸 USA |